ArticleApplied biochemistry and biotechnology2026
Gold Nanoparticles Green-Synthesized from Conium Maculatum: A Promising Anticancer Agent Targeting Apoptosis Pathways in PANC-1.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology has emerged as an effective tool for developing environmentally safe anticancer nanoparticles. Traditionally, nanoparticles have been constructed using many techniques, but unfortunately, these processes have a detrimental effect on the natural environment. The fusion of nanoparticles using plant extract is an alternative and conservative approach. Our study investigates the green synthesis of gold nanoparticles (AuNPs) utilizing Conium maculatum (CM) extract and evaluates their potential as anticancer agents targeting pancreatic cancer (PANC-1) cells. The CM-AuNPs were characterized using UV-vis spectroscopy, TEM, SEM, and FTIR, confirming spherical nanoparticles with good colloidal stability between 9 and 13 nm. The DPPH test was used to evaluate the antioxidant properties of the CM extract, revealing an IC50 value of 96.14 µg/mL, while total phenolic content (TPC) was measured at 761.5 mg GAE/g. The synthesized CM-AuNPs exhibited significant dose-dependent cytotoxicity against PANC-1 cells, with an IC50 (4.02 µg/mL) value notably lower than the CM extract alone (10.70 µg/mL), indicating enhanced efficacy. Flow cytometry analysis showed increased apoptosis, evidenced by the reduction of Bcl-2 levels and the elevation of Bax and Caspase-3, confirming a mitochondria-mediated caspase-dependent apoptotic pathway. Additionally, CM-AuNPs induced reactive oxygen species (ROS) generation, further contributing to the observed apoptosis. This study emphasizes the significant prospects of green-synthesized CM-AuNPs as an eco-friendly therapeutic alternative for pancreatic cancer treatment. In addition, future studies should delineate additional molecular pathways affected by C. maculatum-derived AuNPs and evaluate their cytotoxicity in other pancreatic cancer cell lines and in vivo mouse models.
Indexed as
Identifiers
41632340What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.